BSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
NSE Live
Oct 30, 15:40Prev. Close
129.85
Open Price
118.90
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Sotac Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 11.05 | 11.05 | 8.05 | 2.30 | 2.30 | |
| Total Share Capital | 11.05 | 11.05 | 8.05 | 2.30 | 2.30 | |
| Reserves and Surplus | 42.20 | 34.21 | 1.94 | 4.32 | 0.19 | |
| Total Reserves and Surplus | 42.20 | 34.21 | 1.94 | 4.32 | 0.19 | |
| Total Shareholders Funds | 53.25 | 45.26 | 9.99 | 6.62 | 2.49 | |
| Minority Interest | 5.17 | 4.07 | 0.23 | 0.00 | 0.07 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 14.19 | 12.13 | 7.77 | 0.97 | 9.28 | |
| Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.28 | 0.00 | 0.05 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 0.16 | 0.14 | 0.10 | 0.06 | 0.04 | |
| Total Non-Current Liabilities | 14.36 | 12.27 | 8.14 | 1.03 | 9.37 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 29.51 | 12.73 | 14.27 | 6.42 | 7.85 | |
| Trade Payables | 18.94 | 28.89 | 25.39 | 19.74 | 13.02 | |
| Other Current Liabilities | 1.56 | 1.33 | 4.09 | 0.26 | 1.45 | |
| Short Term Provisions | 1.54 | 0.78 | 2.06 | 1.18 | 0.45 | |
| Total Current Liabilities | 51.55 | 43.73 | 45.81 | 27.61 | 22.76 | |
| Total Capital And Liabilities | 124.33 | 105.33 | 73.64 | 35.25 | 34.70 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 46.77 | 33.60 | 24.01 | 8.79 | 16.56 | |
| Intangible Assets | 0.02 | 0.01 | 0.00 | 0.01 | 0.00 | |
| Capital Work-In-Progress | 0.20 | 5.12 | 0.04 | 0.00 | 0.00 | |
| Fixed Assets | 46.99 | 38.73 | 24.05 | 8.80 | 16.56 | |
| Non-Current Investments | 3.78 | 2.10 | 0.00 | 0.39 | 0.13 | |
| Deferred Tax Assets [Net] | 1.30 | 1.43 | 0.00 | 0.02 | 0.00 | |
| Long Term Loans And Advances | 0.52 | 0.53 | 0.54 | 0.16 | 0.66 | |
| Other Non-Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Assets | 54.50 | 44.68 | 26.50 | 9.38 | 17.35 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.17 | |
| Inventories | 20.26 | 18.01 | 13.64 | 5.39 | 4.83 | |
| Trade Receivables | 34.11 | 26.29 | 14.94 | 12.25 | 5.88 | |
| Cash And Cash Equivalents | 1.56 | 3.42 | 9.68 | 0.03 | 0.27 | |
| Short Term Loans And Advances | 0.52 | 0.17 | 0.01 | 2.67 | 0.16 | |
| OtherCurrentAssets | 13.37 | 12.76 | 8.86 | 5.53 | 6.04 | |
| Total Current Assets | 69.83 | 60.65 | 47.14 | 25.88 | 17.35 | |
| Total Assets | 124.33 | 105.33 | 73.64 | 35.25 | 34.70 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 0.00 | 0.00 | 0.00 | 0.40 | 0.00 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Non-Current Investments Unquoted Book Value | 0.00 | 0.00 | 0.00 | 0.39 | 0.13 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Current Investments Unquoted Book Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.17 |
30.10.2024
Sotac Pharma Consolidated September 2024 Net Sales at Rs 27.35 crore, up 2.52% Y-o-Y
27.08.2024
Sotac Pharma Consolidated June 2024 Net Sales at Rs 25.25 crore, up 1.13% Y-o-Y
19.08.2024
Sotac Pharma Standalone June 2024 Net Sales at Rs 13.01 crore, down 31.18% Y-o-Y
18.06.2024
Sotac Pharma Consolidated March 2024 Net Sales at Rs 26.45 crore, up 46.24% Y-o-Y
30.10.2024
Sotac Pharma Consolidated September 2024 Net Sales at Rs 27.35 crore, up 2.52% Y-o-Y
27.08.2024
Sotac Pharma Consolidated June 2024 Net Sales at Rs 25.25 crore, up 1.13% Y-o-Y
19.08.2024
Sotac Pharma Standalone June 2024 Net Sales at Rs 13.01 crore, down 31.18% Y-o-Y
18.06.2024
Sotac Pharma Consolidated March 2024 Net Sales at Rs 26.45 crore, up 46.24% Y-o-Y